Who Paid My Doc
Mark Lopez
Pediatric Emergency Medicine Augusta, GA Medical Doctor
NPI 1053420257 CMS profile 592344
1120 15Th St, Augusta, GA 30912
General payments
$15
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Mark Lopez of Augusta, GA is reported in the CMS Open Payments database as having received $15 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 8th percentile of Pediatric Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $15 | 1 |
Beside peers
- Mark Lopez
- Pediatric Emergency Medicine median
- Middle half of Pediatric Emergency Medicine
- National median
In program year 2025, general payments to Mark Lopez were reported at $0. Among 239 Pediatric Emergency Medicine profiles paid that year, the median was $53 and the middle half received between $24 and $126.
Show as a table
| Year | Mark Lopez | Pediatric Emergency Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $65 | $22–$126 | $163 |
| 2020 | $0 | $25 | $18–$99 | $114 |
| 2021 | $0 | $45 | $24–$128 | $132 |
| 2022 | $0 | $77 | $23–$150 | $149 |
| 2023 | $15 | $52 | $22–$127 | $160 |
| 2024 | $0 | $63 | $22–$143 | $164 |
| 2025 | $0 | $53 | $24–$126 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 21 billing codesPaid by Medicare
$25,157
Medicare patients
174
Services billed
258
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 48% | |
| Diabetes | 46% | |
| Ischemic heart disease | 40% | |
| Chronic kidney disease | 39% | |
| Heart failure | 35% | |
| Depression | 32% | |
| Atrial fibrillation | 25% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Emergency Medicine in Georgia
Claudia Morris
Pediatric Emergency Medicine · Atlanta, GA
Rebecca Reamy
Pediatric Emergency Medicine · Columbus, GA
Larry Mellick
Pediatric Emergency Medicine · Augusta, GA
Amy Baxter
Pediatric Emergency Medicine · Atlanta, GA
Shayna Smith
Pediatric Emergency Medicine · Atlanta, GA
Sarah Lazarus
Pediatric Emergency Medicine · Atlanta, GA
Related records
Pediatric Emergency Medicine in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Emergency Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.